Related Experiment Video

Updated: Aug 14, 2026

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
06:32

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 2, 2010

Molecular biology of medulloblastoma therapy

Scott L Pomeroy1, Lisa-Marie Sturla

  • 1Department of Neurology, Enders 260, Children's Hospital, Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115, USA. scott.pomeroy@childrens.harvard.edu

Pediatric Neurosurgery
|January 22, 2004
PubMed

Insights

Molecular studies reveal cell signaling pathways driving medulloblastoma growth. New tissue collection methods are needed for analyzing unstable molecules, crucial for future brain tumor therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Medulloblastomas are aggressive brain tumors with complex molecular underpinnings.
  • Conventional histological techniques may not preserve crucial molecular information.
  • Understanding cell signaling pathways is key to targeted therapies.

Purpose of the Study:

  • To elucidate the role of cell signaling pathways in medulloblastoma proliferation.
  • To identify novel molecular markers for prognosis and therapeutic targeting.
  • To highlight the need for advanced tissue collection methods for molecular analysis.

Main Methods:

  • Molecular biological analyses of medulloblastoma tissues.
  • Identification and characterization of key cell signaling pathways.
  • Assessment of molecular markers for prognostic value.

Main Results:

  • Key cell signaling pathways promoting medulloblastoma growth have been identified.
  • Specific molecular markers with prognostic significance have been discovered.
  • Conventional tissue handling degrades molecules essential for advanced analysis.

Conclusions:

  • Molecular insights are revolutionizing medulloblastoma understanding and treatment.
  • Identified markers offer potential for improved patient outcomes.
  • Novel tissue collection protocols are essential for future molecular diagnostics and therapies in brain tumors.

More Related Videos

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 4, 2010

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model09:02

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Published on: September 27, 2024

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...